Thaerapy BV and Resyca® BV Announce Exclusive License Agreement for Soft Mist Inhaler Technology

Huateng Pharma Announced To Attend INTERPEHX Week Tokyo - in-PHARMA JAPAN In July 2023

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

Packaging Solutions Ensuring Product Integrity: Glass and Plastic Varieties

Alfa Chemistry: Test Kits Provides New Options to Transform Testing Strategy

Torx® 2.0 - Unique molecule life cycle platform released

Torx® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities to deliver unrivalled seamless integration across the drug discovery Design-Make-Test-Analyze (DMTA) cycle.

Creative Biolabs' Exhibition at BIO 2023 Accomplished

Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.

Creative Proteomics Expands Proteomics Services with Launch of N-Terminal Edman Degradation Service

Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research

Creative Proteomics Revolutionizes DNA-Protein Interaction Studies with Cutting-Edge DNA Pull Down Service

PhenoTips Announces Appointment of Dr. Pawel Buczkowicz As New CEO

PhenoTips announces the appointment of Dr. Pawel Buczkowicz as Chief Executive Officer. This decision follows Dr. Orion Buske stepping down from the position of CEO, a role he has held since 2018, and returning in a senior leadership role in the coming months. The Canada-based software company and producer of the world’s first Genomic Health Record will see Dr. Buczkowicz take over the role of CEO and further the company’s trajectory towards widespread adoption, enabling global digital data unification and standardization in genomic medicine.

NCC Group advises on UK Government’s Manual for Smart Streets

NCC Group, one of the world’s largest cybersecurity consulting firms, has collaborated with the Department for Transport and the Transport Technology Forum to develop the Manual for Smart Streets, a newly launched guide for UK authorities and other key stakeholders in road infrastructure. It supports authorities who are conceiving, designing and implementing smart street systems in the UK, and was created to provide guidance, examples and practical pointers, allowing them to make best use of technology and improve how the UK travels.

MIB Agents’ Community of Families Has Awarded Over $1.5M in Grants to Research Pediatric Bone Cancer

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.

Cancer Gene Therapy | Current Insight with Future Aspect Analysis

The global cancer gene therapy industry size accounted for USD 2.04 billion in 2022 and is estimated to achieve a market size of USD 12.75 billion by 2032 growing at a CAGR of 20.1% from 2023 to 2032.

Unique molecule life cycle platform released: Torx® 2.0

Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.

Sygnature Discovery launches its LPS in vivo model to profile early-stage anti-inflammatory drugs

70% Of Major Pharmaceutical Companies And CROs Surveyed Have Adopted Digital Pathology

Report reveals initial deployment of legacy systems has paved the way for imminent shift to modern software needed to accelerate AI-powered drug R&D

Kalderos' 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients

Kalderos’ 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients

James Rickard appointed Chief Scientific Officer of Richmond Research Institute

CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research

Global Cellular Health Screening Market was valued at $2.6 billion in 2022 and is set to witness a CAGR of 9% by 2027 - Growing Applications in Personalized Medicine

Government initiatives towards preventive healthcare, growing funding & investments in R&D activities, adoption of direct-to-consumer approach, increasing applications in personalized medicine and growing burden of chronic diseases are some of the major factors driving the growth of cellular health screening market.